Skip to main content
Clinical Trials/ITMCTR2200005606
ITMCTR2200005606
Recruiting
Phase 4

A randomized, double-blind, parallel-controlled, multi-center clinical trial of traditional Chinese medicine variety protection with Wuhu Oral Liquid in the treatment of acute soft tissue injury (Qi stagnation and blood stasis syndrome)

onghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine0 sitesTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
acute soft tissue injury
Sponsor
onghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational study
Sex
All

Investigators

Sponsor
onghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • (1\) Meet the diagnostic criteria for acute soft tissue injury in Western medicine;
  • (2\) Comply with the standard of TCM syndrome differentiation of qi stagnation and blood stasis;
  • (3\) The duration of soft tissue injury is less than or equal to 48 hours;
  • (4\) VAS score of resting pain score of the affected area is more than 3 points, and activity pain is less than 9 points;
  • (5\) Age 18 to 65 years old (including 18 and 65 years old), gender is not limited;
  • (6\) Subjects gave informed consent, voluntarily tested and signed the informed consent form.

Exclusion Criteria

  • (1\) Soft tissue injury sites with fractures, bone cracks, open wounds, or complete rupture of soft tissues such as muscles, tendons, and ligaments;
  • (2\) \=2 soft tissue injury sites;
  • (3\) When the affected part is the joint part, other inflammatory and painful diseases, such as rheumatoid arthritis, psoriatic arthritis, gout, tumor, villonodular synovitis, joint trauma, septic arthritis, tuberculosis Arthritis;
  • (4\) Use short\-acting non\-steroidal anti\-inflammatory drugs or traditional Chinese medicines with the functions of promoting blood circulation and removing blood stasis, reducing swelling and relieving pain within 12 hours before the first dose; use long\-acting or sustained\-release non\-steroidal anti\-inflammatory drugs within 3 days; use corticosteroids within one week Steroids or antibiotics; those who have received acupuncture, physiotherapy, massage and other treatments during the course of the disease;
  • (5\) Complicated with severe heart disease, renal failure, hematological disease; abnormal liver and kidney function ALT, AST, TBiL, Cr \> upper limit of normal;
  • (6\) Pregnant, suspected pregnancy, lactating female patients or patients who refuse to use contraceptives during the study (including male and female);
  • (7\) Those who cannot cooperate with physical or mental diseases (such as blindness, deafness, muteness, intellectual disability, mental disorder, etc.), or those with serious diseases (such as tumors, etc.) that affect survival;
  • (8\) Suspect or have a history of alcohol or drug abuse;
  • (9\) Those who are known to be allergic to test drugs, excipients (alcohol) or emergency drugs specified in the protocol;
  • (10\) Engaged in high\-altitude, high\-risk operations, or driving workers;

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
A randomized, double-blind, parallel-controlled, multicenter trial to evaluate the effectiveness and safety of Xiyanping injection combined with azithromycin and azithromycin in the treatment of mycoplasma pneumoniae pneumonia in childreMycoplasma pneumoniae pneumonia
ITMCTR2000003093The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Recruiting
Phase 4
A randomized, double-blind, parallel-controlled, multi-center clinical trial of Chinese medicine variety protection with Niuhuang Qinggan Capsule in the treatment of common cold (wind-heat syndrome)Common cold (wind-heat syndrome)
ITMCTR2200005537The Second Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine
Recruiting
Phase 4
A randomized, double-blind, parallel-controlled, multicentre clinical study to evaluate the efficacy and safety of Sechang Zhixie Powder in the treatment of acute watery diarrhea in childreAcute watery diarrhea
ITMCTR2100004284First Teaching Hospital of Tianjin University of TCM
Not yet recruiting
Phase 1
A randomized, double-blind, parallel-controlled, multi-center clinical trial of the effectiveness and safety of Fuyanxiao Capsule in the treatment of pelvic inflammatory diseases (damp-heat stasis syndrome)
ITMCTR2100005028Dongfang Hospital, Beijing University of Chinese Medicine
Recruiting
Phase 2
Phase II Clinical Trial of Qingke Pingchuan Granules in Treating Acute Bronchitis in ChildreAcute bronchitis in children
ITMCTR2100004581Shanghai Traditional Chinese Medicine Hospital